GelrinC

Regentis Develops Solvent-Free GelrinC Process Boost

HERZLIYA, Israel, March 17, 2026 Regentis Biomaterials Ltd. has announced a breakthrough solvent-free manufacturing process for its lead regenerative...

By cGxPwire Editor
March 18, 2026

.Clinical

Regentis Expands Phase III GelrinC Trial Across U.S. Sites

HERZLIYA, Israel, January 29, 2026 — Regentis Biomaterials Ltd. announced a significant expansion of its U.S. clinical site network...

By cGxPwire Editor
January 30, 2026

MedTech

Regentis IPO Fuels Advancement of GelrinC Regenerative MedTech

HERZLIYA, ISRAEL — December 5, 2025 — Regentis Biomaterials Ltd., a regenerative medicine MedTech company developing innovative tissue-repair solutions,...